Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Neoplasms 2Colonic Neoplasms 2Adenomatous Polyposis Coli 2Adenoma 2Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Overweight 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplastic Syndromes, Hereditary 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Intestinal Neoplasms 1Intestinal Diseases 1Hepatoblastoma 1Hepatitis 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Esophageal Neoplasms 1Duodenal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Chemical and Drug Induced Liver Injury 1

Interventions

Endoscopy 13Endoscopy, Digestive System 12Radiofrequency Ablation 7Esomeprazole 7Biopsy 7Endoscopic Mucosal Resection 6Specimen Handling 4Proflavine 4Omeprazole 4Aspirin 4Gastroscopy 3YF 476 2Proton Pump Inhibitors 2Photochemotherapy 2Narrow Band Imaging 2Microscopy, Confocal 2Metformin 2Lansoprazole 2Itraconazole 2Endoscopes 2Diagnostic Imaging 2Dexlansoprazole 2Cryotherapy 2Cryosurgery 2Breath Tests 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2rofecoxib 1polyphenon E 1plecanatide 1omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Barrett Esophagus × Ursodeoxycholic Acid × Clear all
NCT01097304 2017-12-19

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

National Cancer Institute (NCI)

Phase 2 Completed
36 enrolled 10 charts
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡